Individualise treatment options for type 2 diabetes patients using blood glucose-lowering medicines in line with the new Australian guidelines.
RACGP 40 (Category 1) QI&CPD points (QI activity)Toggle information
This activity has been accredited by the RACGP for 40 (Category 1) points (QI activity) for the 2017–2019 triennium (activity ID number 91695).
ACRRM 30 PRPD pointsToggle information
This activity has been accredited by ACRRM for 30 PRPD points for the 2017–2019 triennium (code 7322).
- Recognised for the Practice Incentives Program Quality Prescribing Incentive (PIP QPI)
Management of diabetes can be challenging, with many patients not achieving recommended targets for HbA1c, blood pressure or cholesterol. Adherence is also a complicating factor because 45% to 70% of patients do not take their metformin as prescribed.
- Complete the Clinical e-Audit for only 10 patients and generate personalised management plans to help you guide their management.
- Review how your practice measures up to current Australian guideline recommendations.
- Use a stepped approach to managing glucose control, based on the latest treatment algorithm for combining diabetes medicines when metformin therapy is no longer enough.
- Manage glycaemic control within a framework of absolute cardiovascular risk.
Our Clinical e-Audits are free quality improvement activities that help GPs review their current prescribing practice for patients with certain conditions, compared with current best practice guidelines.
- completing electronic data collection for 10 patients
- securely submitting de-identified data online
- receiving immediate patient-specific feedback to assist implementation of changes to practice
- reviewing individual and peer feedback results based on best practice clinical indicators
- recording progress of individual patients automatically identified for review
- reflecting on improvements in practice.
On completion of this activity you will be able to:
- apply a recommended step-wise approach to the management of diabetes.
- determine and achieve each patient’s guideline-recommended HbA1c target.
- recognise the extent of non-adherence to glucose-lowering medicines in the management of diabetes and encourage use of strategies to optimise adherence.
- select a second-line (add-on) diabetes medicine, based on the medicine profile and patient factors, in line with the most recent Australian guidelines.
- have access to evidence-based information to update your knowledge
- receive practical advice to provide to your patients
- generate a management plan for each patient
- receive immediate feedback and be able to compare your results with those of your peers.